TrumpRx, the Trump administration’s much-anticipated direct-to-consumer drug platform, is expected to launch on Thursday.
Good morning, and thank you for joining us today for Stewart's Fourth Quarter and Full Year 2025 Earnings Conference Call. We will be discussing results that were released yesterday after the close.